A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-based Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Protocol No
HOFFMANN-WO39608-MORPHEUS
Principal Investigator
Ben George
Phase
I/II
Summary
You were selected as a possible participant in this study because you have pancreatic cancer that has spread to other parts of your body (metastatic disease). If you have not received any treatment for metastatic disease, you will take part in Cohort 1 of this study. If you have previously received chemotherapy for pancreatic cancer, you will take part in Cohort 2 of this study.
Description
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Share This: